Early research (Phase 1)Study completedNCT03263936
What this trial is testing
Epigenetic Reprogramming in Relapse/Refractory AML
Who this might be right for
Acute Myelogenous Leukemia
Therapeutic Advances in Childhood Leukemia Consortium 37
Showing 20 of 0 results